Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022
Stacey Adjei, Kai Hong, Noelle‐Angelique Molinari, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 37, pp. 1182-1189
Open Access | Times Cited: 153

Showing 26-50 of 153 citing articles:

Age-associated differences in mucosal and systemic host responses to SARS-CoV-2 infection
Jillian H. Hurst, Aditya Mohan, Trisha Dalapati, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx, New York
Justin Y. Lu, Alexandra Buczek, Roman Fleysher, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15277-e15277
Open Access | Times Cited: 13
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting
Yoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 811-811
Open Access | Times Cited: 12
A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study
Jingxing Li, Pei‐Lun Liao, James Cheng‐Chung Wei, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 12
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 12
Vaccination, immunity, and the changing impact of COVID-19 on infant health
Florencia Torche, Jenna Nobles
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 12
Air pollution and meteorology as risk factors for COVID-19 death in a cohort from Southern California
Michael Jerrett, Claudia Nau, Deborah Rohm Young, et al.
Environment International (2022) Vol. 171, pp. 107675-107675
Open Access | Times Cited: 20
Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?
Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
CT Scan-Derived Muscle, But Not Fat, Area Independently Predicts Mortality in COVID-19
S.I.J. van Bakel, Hester A. Gietema, Patricia M. Stassen, et al.
CHEST Journal (2023) Vol. 164, Iss. 2, pp. 314-322
Open Access | Times Cited: 11
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era
Mohanad Al‐Obaidi, Ahmet B. Gungor, Sangeetha Murugapandian, et al.
The American Journal of Medicine (2023) Vol. 136, Iss. 6, pp. 577-584
Open Access | Times Cited: 11
LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage
Siva Nageswara Rao Gajula, Ankita Sahebrao Khairnar, Pallavi Jock, et al.
Expert Review of Proteomics (2023) Vol. 20, Iss. 1-3, pp. 5-18
Closed Access | Times Cited: 10
The burden of incidental SARS-CoV-2 infections in hospitalized patients across pandemic waves in Canada
Finlay A. McAlister, Jeffrey P. Hau, Clare L. Atzema, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Big data evidence of the impact of COVID-19 hospitalizations on mortality rates of non-COVID-19 critically ill patients
Bruno Wichmann, Roberta Moreira Wichmann
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
Josh J. Carlson, V. Foos, Adam Kasle, et al.
Value in Health (2023) Vol. 27, Iss. 2, pp. 164-172
Open Access | Times Cited: 10
Insights into Covid-19 mortality: A comprehensive study of cardiovascular sensitivity, gender, race, and geography trends in the United States (2020-2023)
Adarsh Raja, Owais Khan, Raja Subhash Sagar, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102435-102435
Closed Access | Times Cited: 3
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
Juan Shi, Gang Wang, Jian Zheng, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 17
DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19
Yinchun Su, Jiashuo Wu, Xiangmei Li, et al.
Computers in Biology and Medicine (2023) Vol. 159, pp. 106969-106969
Open Access | Times Cited: 9
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era
Srilekha Sridhara, Ahmet B. Gungor, Halil Erol, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0279326-e0279326
Open Access | Times Cited: 9
Prevalence of Pneumonia Among Patients Who Died with COVID-19 Infection in Ancestral Versus Omicron Variant Eras
Mark M. Hammer, Aaron D. Sodickson, Andrew D. A. Marshall, et al.
Academic Radiology (2023) Vol. 31, Iss. 1, pp. 1-6
Open Access | Times Cited: 9
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial
Yanfen Guan, Amy Puenpatom, Matthew G. Johnson, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 11, pp. 1521-1530
Open Access | Times Cited: 9
COVID-19
Kristen Marks, Roy M. Gulick
Annals of Internal Medicine (2023) Vol. 176, Iss. 10, pp. ITC145-ITC160
Closed Access | Times Cited: 9
Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
Leland Shapiro, Sias Scherger, Carlos Franco‐Paredes, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Timing of Intubation in COVID-19: When It Is Too Early and When It Is Too Late
John C. Grotberg, Bryan Kraft
Critical Care Explorations (2023) Vol. 5, Iss. 2, pp. e0863-e0863
Open Access | Times Cited: 8
Clinical and epidemiological features of pediatric population hospitalized with COVID-19: a multicenter longitudinal study (March 2020–December 2021) from Pakistan
Qalab Abbas, Farah Khalid, Fatima Farrukh Shahbaz, et al.
The Lancet Regional Health - Southeast Asia (2023) Vol. 11, pp. 100176-100176
Open Access | Times Cited: 8
Mortality in Norway and Sweden during the COVID-19 pandemic 2020–22: A comparative study
Per‐Henrik Zahl, Örjan Hemström, Rune Johansen, et al.
Journal of Infection and Public Health (2023) Vol. 17, Iss. 4, pp. 719-726
Open Access | Times Cited: 8

Scroll to top